Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beral V., Hermon C., Muñoz N., Devesa S. S. Cervical cancer. Cancer Surv. 1994;19-20:265–285. [PubMed] [Google Scholar]
- Buntinx F., Brouwers M. Relation between sampling device and detection of abnormality in cervical smears: a meta-analysis of randomised and quasi-randomised studies. BMJ. 1996 Nov 23;313(7068):1285–1290. doi: 10.1136/bmj.313.7068.1285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mitchell H., Medley G. Longitudinal study of women with negative cervical smears according to endocervical status. Lancet. 1991 Feb 2;337(8736):265–267. doi: 10.1016/0140-6736(91)90870-u. [DOI] [PubMed] [Google Scholar]
- Prentice R. L. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med. 1989 Apr;8(4):431–440. doi: 10.1002/sim.4780080407. [DOI] [PubMed] [Google Scholar]
- Sasieni P. D., Cuzick J., Lynch-Farmery E. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer. 1996 Apr;73(8):1001–1005. doi: 10.1038/bjc.1996.196. [DOI] [PMC free article] [PubMed] [Google Scholar]